• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于钆塞酸二钠增强MRI的影像组学在肝胆期等或高信号肝癌与肝局灶性结节增生鉴别诊断中的应用价值]

[The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].

作者信息

Mao H Y, Yu Y X, Zhang J Y, Zhang T, Fan Y F, Hu S, Wang X M, Hu C H

机构信息

Department of Radiology, the First Affiliated Hospital of Soochow University, Institute of Medical Imaging of Soochow University, Suzhou 215006, China.

Department of Radiology, Nantong No.3 People's Hospital, Nantong 226000, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2023 Sep 5;103(33):2599-2606. doi: 10.3760/cma.j.cn112137-20230117-00095.

DOI:10.3760/cma.j.cn112137-20230117-00095
PMID:37650206
Abstract

To investigate the application value of Gd-EOB-DTPA enhanced MRI based radiomics model in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia (FNH) in hepatobiliary phase. A total of 88 patients with HCC or FNH confirmed by surgical or puncture pathology who underwent preoperative Gd-EOB-DTPA enhanced MRI (all lesions showed iso-or hyperintensity in hepatobiliary phase) between January 2015 and February 2023 in The First Affiliated Hospital of Soochow University and Nantong No.3 People's Hospital were retrospectively evaluated, which including 58 males and 30 females, aged [(]56 (40, 67) years, including 61 patients with HCC and 27 patients with FNH. The included cases were divided into training (43 cases of HCC, 19 cases of FNH) and validation cohort (18 cases of HCC, 8 cases of FNH) in the ratio of 7∶3 using the random seeding method. A total of 1 781 radiomics features were extracted from Gd-EOB-DTPA enhanced MRI in the arterial, portal and hepatobiliary phases, respectively. The independent three phase models, combined three phases model and combined clinical-radiomics model was established using Auto-Encoder (AE) and Native Bayes (NB) classifier, respectively. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of these models. DeLong test was used to compare the areas under curve (AUC). In the validation cohort, the combined clinical-radiomics model had the highest AUC (AUC=0.938, 95%: 0.828-1.000). The AUC, accuracy, sensitivity, specificity of the clinical-radiomics combined model using AE classifier in the validation cohort were 0.896 (95%: 0.760-1.000), 88.5%, 88.9%, 87.5%. The AUC of the clinical-radiomics combined model using NB classifier in the validation cohort were 0.938 (95%: 0.828-1.000), 92.3%, 88.9%, 100.0%. Gd-EOB-DTPA enhanced MRI combined clinical-radiomics model has certain value in preoperative differentiation of iso-or hyperintensity in the hepatobiliary phase HCC and FNH, with a high accuracy, sensitivity and specificity.

摘要

探讨基于钆塞酸二钠(Gd-EOB-DTPA)增强磁共振成像(MRI)的影像组学模型在肝胆期等或高信号肝细胞癌(HCC)与肝局灶性结节性增生(FNH)鉴别诊断中的应用价值。回顾性分析2015年1月至2023年2月在苏州大学附属第一医院和南通市第三人民医院接受术前Gd-EOB-DTPA增强MRI检查(所有病灶在肝胆期呈等或高信号)且经手术或穿刺病理确诊为HCC或FNH的88例患者,其中男性58例,女性30例,年龄[56(40,67)岁],包括HCC患者61例,FNH患者27例。采用随机种子法将纳入病例按7∶3的比例分为训练组(HCC 43例,FNH 19例)和验证组(HCC 18例,FNH 8例)。分别从Gd-EOB-DTPA增强MRI的动脉期、门脉期和肝胆期提取1781个影像组学特征。分别使用自动编码器(AE)和朴素贝叶斯(NB)分类器建立独立三期模型、联合三期模型和联合临床-影像组学模型。采用受试者操作特征(ROC)曲线评估这些模型的诊断性能。使用德龙检验比较曲线下面积(AUC)。在验证组中,联合临床-影像组学模型的AUC最高(AUC = 0.938,95%:0.828 - 1.000)。验证组中使用AE分类器的临床-影像组学联合模型的AUC、准确率、灵敏度、特异度分别为0.896(95%:0.760 - 1.000)、88.5%、88.9%、87.5%。验证组中使用NB分类器的临床-影像组学联合模型的AUC为0.938(95%:0.828 - 1.000)、92.3%、88.9%、100.0%。Gd-EOB-DTPA增强MRI联合临床-影像组学模型在术前鉴别肝胆期等或高信号HCC与FNH中具有一定价值,具有较高的准确率、灵敏度和特异度。

相似文献

1
[The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].[基于钆塞酸二钠增强MRI的影像组学在肝胆期等或高信号肝癌与肝局灶性结节增生鉴别诊断中的应用价值]
Zhonghua Yi Xue Za Zhi. 2023 Sep 5;103(33):2599-2606. doi: 10.3760/cma.j.cn112137-20230117-00095.
2
Gd-EOB-DTPA enhanced MRI nomogram model to differentiate hepatocellular carcinoma and focal nodular hyperplasia both showing iso- or hyperintensity in the hepatobiliary phase.钆塞酸二钠增强 MRI 列线图模型鉴别肝胆期呈等或高信号的肝细胞肝癌和局灶性结节增生。
BMC Med Imaging. 2024 Aug 12;24(1):211. doi: 10.1186/s12880-024-01382-6.
3
[Diagnostic value of Gd-EOB-DTPA-enhanced MRI radiomics models for dual-phenotype hepatocellular carcinoma].钆塞酸二钠增强MRI影像组学模型对双表型肝细胞癌的诊断价值
Zhonghua Yi Xue Za Zhi. 2024 Sep 3;104(34):3228-3235. doi: 10.3760/cma.j.cn112137-20240708-01499.
4
The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.钆塞酸二钠增强磁共振成像对肝脏局灶性结节增生的诊断价值:一项系统评价与Meta分析
Eur Radiol. 2015 Apr;25(4):950-60. doi: 10.1007/s00330-014-3499-9. Epub 2014 Dec 24.
5
Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.术前预测肝细胞癌微血管侵犯:钆塞酸二钠增强 MRI 的影像组学模型。
Eur Radiol. 2019 Sep;29(9):4648-4659. doi: 10.1007/s00330-018-5935-8. Epub 2019 Jan 28.
6
[Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].[钆塞酸二钠增强磁共振成像:局灶性结节性增生与肝细胞腺瘤的鉴别诊断]
Acta Med Port. 2011 Dec;24 Suppl 2:531-8. Epub 2011 Dec 31.
7
Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.钆塞酸二钠增强 MRI 的放射组学分析预测肝细胞癌的 Ki-67 表达。
BMC Med Imaging. 2021 Jun 15;21(1):100. doi: 10.1186/s12880-021-00633-0.
8
[Differentiation between hyperintense hepatocellular carcinoma and focal nodular hyperplasia in hepatobiliary phase with multimodal parameters of magnetic resonance imaging].[利用磁共振成像多模态参数在肝胆期鉴别高强度肝细胞癌与局灶性结节性增生]
Zhonghua Gan Zang Bing Za Zhi. 2022 Oct 20;30(10):1069-1073. doi: 10.3760/cma.j.cn501113-20200803-00432.
9
HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.增强型肝细胞腺瘤及其在钆塞酸增强 MRI 中的与 FNH 鉴别
BMC Med Imaging. 2021 Feb 15;21(1):28. doi: 10.1186/s12880-021-00552-0.
10
Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.基于钆塞酸二钠增强 MRI 成像的放射组学临床模型:肝细胞癌免疫评分的预处理预测。
Eur Radiol. 2019 Aug;29(8):4177-4187. doi: 10.1007/s00330-018-5986-x. Epub 2019 Jan 21.